KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

Awards News
March 26, 2026
During this week’s 2026 KHA Quality Conference, attendees from multiple hospitals provided live, digital poster presentations.
Awards News
March 25, 2026
KHA recognized seven hospitals and one health system for their outstanding achievements in quality improvement during its Annual Quality Conference this week.
News
March 20, 2026
On March 19, KHA hosted its first in a series of Regional Workplace Violence Prevention Symposiums.